Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia-Reference-Cited by-同舟云学术

Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia

Published:2017-11 Issue:11 Volume:29 Page:1223-1230
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:European Journal of Gastroenterology & Hepatology

Author:

Dolmazashvili Ekaterine,Abutidze Akaki,Chkhartishvili Nikoloz,Karchava Marine,Sharvadze Lali,Tsertsvadze Tengiz

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference48 articles.

1. Evolving epidemiology of hepatitis C virus

2. Global epidemiology and genotype distribution of the hepatitis C virus infection

3. Changing trends in hepatitis C-related mortality in the United States, 1995-2004

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of Duration of Transjugular Intrahepatic Portosystemic Shunt (TIPS) Procedure: A Retrospective Single-Center Study;Cureus;2024-07-30

2. Sustained virological response in chronic hepatitis C patients by direct-acting antiviral treatment significantly reduces liver stiffness over 24 weeks posttreatment;Medicine;2024-05-10

3. Treatment of Chronic Hepatitis C in Older Adults;Korean Journal of Clinical Geriatrics;2023-12-30

4. Fibrosis resolution in the mouse liver: Role of Mmp12 and potential role of calpain 1/2;Matrix Biology Plus;2023-02

5. Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study;World Journal of Gastroenterology;2022-08-14